Product Information
TIMOLOL MALEATE 0.5% EYE DROPS is a generic product labeled by Bausch & Lomb Americas Inc., priced at $1.0592 per ML under NDC 82260081305. Its NADAC has been published 119 times since May 15, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AT1.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Bausch & Lomb Americas Inc.NDC
82260081305
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA018086FDA Approved
Before 1982
TE Code
AT1
On Market Since
6/1/2020
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has been published 119 times since May 15, 2024, and over the history we have for it it has risen 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0592 per ML |
|---|---|
| All-time high | $1.1256 (Apr 16, 2025) |
| All-time low | $0.8871 (Nov 20, 2024) |
| 52-week high | $1.0969 |
| 52-week low | $1.0406 |
| Median price | $1.0800 |
| Average price | $1.0600 |
| Largest weekly change | +19.3% (Jun 19, 2024) |
| Weeks tracked | 119 |
| Tracking since | May 15, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.5% EYE DROPS, manufactured by Bausch & Lomb Americas Inc., is $1.0592 per ML (NDC 82260081305), effective Aug 19, 2026.
How has the price of TIMOLOL MALEATE 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has risen 9.0%. It has been tracked across 119 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.5% EYE DROPS?
Since May 15, 2024, the NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has ranged from a low of $0.8871 (Nov 20, 2024) to a high of $1.1256 (Apr 16, 2025), with a median of $1.0800 per ML.
Are there cheaper alternatives to TIMOLOL MALEATE 0.5% EYE DROPS?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.5% EYE DROPS, is $0.7316 per ML — about 31% below TIMOLOL MALEATE 0.5% EYE DROPS.
Who manufactures TIMOLOL MALEATE 0.5% EYE DROPS?
TIMOLOL MALEATE 0.5% EYE DROPS (NDC 82260081305) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.